Read More

Match Group Beats On Q4 Earnings, Authorizes $1B Share Buy-Back

Match Group reported quarterly earnings of 81 cents per share which beat the analyst consensus estimate of 49 cents by 65.31%. The company reported quarterly sales of $866 million, beating the analyst consensus estimate of $861.22 million by 0.56% and representing a 10.16% increase over sales of $786.15 million from the same period last year.

MTCH

Read More

JetBlue CEO Comments “We Strongly Disagree With The Court’s Ruling”, Requests Expedited Appeal

According to a Reuters report, JetBlue and Spirit are seeking an expedited appeal aimed at reversing a lower court ruling that blocked the proposed $3.8 billion merger of the airlines. The airlines stated that the appeal should be expedited because the court may not have an opportunity to review the decision due to the outside closing date of July 24 of the merger agreement.

JBLU

Read More

What’s Going On With C3is Stock?

C3is shares are moving on heavy trading volume Tuesday with more than 68.3 million shares already traded in the session. According to data from Benzinga Pro, the stock's 100-day average volume is 4.486 million shares. 11.81% of shares are being sold short which may be contributing to the stock's move when combined with its heavy trading volume.

CISS

Read More

Pixelworks Stock Shoots Up After Deal With Walt Disney Studios

Pixelworks announced that the agreement between Walt Disney Studios and Pixelworks will bring a collection of TrueCut Motion graded titles to select home entertainment devices. "Disney once again is extending the boundaries of the home cinematic experience, empowering its filmmakers to delight their audiences, and we are proud to be a part of it," said Richard Miller, GM of TrueCut Motion at Pixelworks.

DIS

Read More

Why Cancer-Drug Developer Kura Oncology Stock Is Up

Kura Oncology, Inc. shares are trading higher Tuesday after the company reported preliminary clinical data from the first 20 patients its Komet-007 Phase 1 dose-escalation trial. Kura reported that all newly diagnosed patients treated with ziftomenib and 7+3 achieved a complete remission (CR) with full count recovery, for a CR rate of 100% (5/5), including four patients with NPM1-m acute myeloid leukemia (AML) and one patient with KMT2A-r AML.

KURA

Read More

Super Micro Computer Reports Q2 Financials, Raises 2024 FY Guidance: Over 100% YOY Sales Increase

Super Micro Computer reported quarterly earnings of $5.59 per share, beating the analyst consensus estimate of $4.93 by 13.39% and representing a 71.47% increase over earnings of $3.26 per share from the same period last year. The company reported quarterly sales of $3.67 billion. Quarterly sales beat the analyst consensus estimate of $3.06 billion by nearly 20% and is a 103.27% increase over sales of $1.8 billion year-over-year.

SMCI